Rebamipide alleviates radiation-induced colitis through improvement of goblet cell differentiation in mice

Journal of Gastroenterology and Hepatology (Australia)

Volumn 33, Issue 4, 2018, Pages 878-886

  Jang, Hyosun ^a   Park, Sunhoo ^a,b   Lee, Janet ^a   Myung, Jae kyung ^a,b   Jang, Won Suk ^a   Lee, Sun Joo ^a   Myung, Hyunwook ^a   Lee, Changsun ^a   Kim, Hyewon ^a   Lee, Seung Sook ^a,b   Jin, Young Woo ^a   Shim, Sehwan ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

Author keywords

colitis; goblet cells; radiation; rebamipide

Indexed keywords

BETA ACTIN; CHECKPOINT KINASE 2; CLAUDIN 3; CLAUDIN 4; GELATINASE B; INTERLEUKIN 1BETA; MATH1 PROTEIN; MESSENGER RNA; MUCIN 2; NOTCH1 RECEPTOR; PROTEIN; PROTEIN ZO1; REBAMIPIDE; TRANSCRIPTION FACTOR HES 1; TREFOIL FACTOR 3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ALANINE; ANTIULCER AGENT; QUINOLONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CELL COUNT; CELL DIFFERENTIATION; COLON EPITHELIUM; COLON TISSUE; CONTROLLED STUDY; DRUG EFFICACY; ENTERITIS; EPITHELIUM CELL; EXPERIMENTAL COLITIS; GOBLET CELL; HISTOPATHOLOGY; HT-29 CELL LINE; IONIZING RADIATION; IRRADIATION; MALE; MOUSE; MRNA EXPRESSION LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION ENTEROPATHY; RADIATION EXPOSURE; TREATMENT DURATION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; COLITIS; COLON; COMPLICATION; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL RADIATION INJURY; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; RADIATION RESPONSE; RADIOTHERAPY;

ALANINE; ANIMALS; ANTI-ULCER AGENTS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLITIS; COLON; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENE EXPRESSION; GOBLET CELLS; HT29 CELLS; HUMANS; MALE; MICE, INBRED C57BL; MUCIN-2; QUINOLONES; RADIATION INJURIES, EXPERIMENTAL; RADIATION, IONIZING; RADIOTHERAPY;

EID: 85040681373     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.14021     Document Type: Article

References (41)

1. Macia IGM, Lucas Calduch A, Lopez EC. Radiobiology of the acute radiation syndrome. Rep Pract Oncol Radiother 2011; 16: 123–130.
2. Bounous G, Le Bel E, Shuster J, Gold P, Tahan WT, Bastin E. Dietary protection during radiation therapy. Strahlentherapie 1975; 149: 476–483.
3. Berthrong M. Pathologic changes secondary to radiation. World J. Surg. 1986; 10: 155–170.
4. Shukla PK, Gangwar R, Manda B et al. Rapid disruption of intestinal epithelial tight junction and barrier dysfunction by ionizing radiation in mouse colon in vivo: protection by N-acetyl-l-cysteine. Am. J. Physiol. Gastrointest. Liver Physiol. 2016; 310: G705–15.
5. Berg RD. Bacterial translocation from the gastrointestinal tract. Trends Microbiol. 1995; 3: 149–154.
6. Seal M, Naito Y, Barreto R, Lorenzetti A, Safran P, Marotta F. Experimental radiotherapy-induced enteritis: a probiotic interventional study. J. Dig. Dis. 2007; 8: 143–147.
7. Dharmani P, Srivastava V, Kissoon-Singh V, Chadee K. Role of intestinal mucins in innate host defense mechanisms against pathogens. J. Innate Immun. 2009; 1: 123–135.
8. Laukoetter MG, Nava P, Nusrat A. Role of the intestinal barrier in inflammatory bowel disease. World J. Gastroenterol. 2008; 14: 401–407.
9. Itoh H, Beck PL, Inoue N, Xavier R, Podolsky DK. A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells. J. Clin. Invest. 1999; 104: 1539–1547.
10. Boshuizen JA, Reimerink JH, Korteland-van Male AM et al. Homeostasis and function of goblet cells during rotavirus infection in mice. Virology 2005; 337: 210–221.
11. Allen A, Hutton DA, Pearson JP. The MUC2 gene product: a human intestinal mucin. Int. J. Biochem. Cell Biol. 1997; 30: 797–801.
12. Shirazi T, Longman RJ, Corfield AP, Probert CS. Mucins and inflammatory bowel disease. Postgrad. Med. J. 2000; 76: 473–478.
13. Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J. Gastroenterol. 2008; 43: 1–17.
14. McCormick DA, Horton LW, Mee AS. Mucin depletion in inflammatory bowel disease. J. Clin. Pathol. 1990; 43: 143–146.
15. Tytgat KM, van der Wal JW, Einerhand AW, Buller HA, Dekker J. Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochem. Biophys. Res. Commun. 1996; 224: 397–405.
16. Renes IB, Verburg M, Van Nispen DJ et al. Epithelial proliferation, cell death, and gene expression in experimental colitis: alterations in carbonic anhydrase I, mucin MUC2, and trefoil factor 3 expression. Int. J. Color. Dis. 2002; 17: 317–326.
17. Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig. Dis. Sci. 1998; 43: 5S–13S.
18. Urashima H, Okamoto T, Takeji Y, Shinohara H, Fujisawa S. Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model. Cornea 2004; 23: 613–619.
19. Urashima H, Takeji Y, Okamoto T, Fujisawa S, Shinohara H. Rebamipide increases mucin-like substance contents and periodic acid Schiff reagent-positive cells density in normal rabbits. J. Ocul. Pharmacol. Ther. 2012; 28: 264–270.
20. Ríos JD, Shatos M, Urashima H, Tran H, Dartt DA. OPC-12759 increases proliferation of cultured rat conjunctival goblet cells. Cornea 2006; 25: 573–581.
21. Ríos JD, Shatos MA, Urashima H, Dartt DA. Effect of OPC-12759 on EGF receptor activation, p44/p42 MAPK activity, and secretion in conjunctival goblet cells. Exp. Eye Res. 2008; 86: 629–636.
22. Lai Y, Zhong W, Yu T et al. Rebamipide promotes the regeneration of aspirin-induced small-intestine mucosal injury through accumulation of β-catenin. PLoS One 2015; 10: e0132031.
23. Shim S, Jang HS, Myung HW et al. Rebamipide ameliorates radiation-induced intestinal injury in a mouse model. Toxicol. Appl. Pharmacol. 2017; 329: 40–47.
24. Min HK, Kim JK, Lee SY et al. Rebamipide prevents peripheral arthritis and intestinal inflammation by reciprocally regulating Th17/Treg cell imbalance in mice with curdlan-induced spondyloarthritis. J. Transl. Med. 2016; 14: 190.
25. Harb AH, Abou Fadel C, Sharara AI. Radiation enteritis. Curr. Gastroenterol. Rep. 2014; 16: 383.
26. Kashima T, Akiyama H, Miura F, Kishi S. Resolution of persistent corneal erosion after administration of topical rebamipide. Clin. Ophthalmol. 2012; 6: 1403–1406.
27. Kinoshita S, Oshiden K, Awamura S, Suzuki H, Nakamichi N, Yokoi N. Rebamipide ophthalmic suspension phase 3 study group. a randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. Ophthalmology 2013; 120: 1158–1165.
28. Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001; 294: 2155–2158.
29. Martinez-Maqueda D, Miralles B. Recio I. The Impact of Food Bio-Actives on Gut Health. 2015: 113–124.
30. Tas S, Ozkul F, Arik MK, Kiraz A, Vural A. The effect of amifostine on bacterial translocation after radiation induced acute enteritis. Acta Cir. Bras. 2016; 31: 156–160.
31. Turner JR. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 2009; 9: 799–809.
32. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 2001; 17: 463–516.
33. Garg P, Ravi A, Patel NR et al. Matrix metalloproteinase-9 regulates MUC-2 expression through its effect on goblet cell differentiation. Gastroenterology 2007; 132: 1877–1889.
34. Zarepour M, Bhullar K, Montero M et al. The mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar Typhimurium colitis. Infect. Immun. 2013; 81: 3672–3683.
35. Chiba S. Notch signaling in stem cell systems. Stem Cells 2006; 24: 2437–2447.
36. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. Signalling downstream of activated mammalian Notch. Nature 1995; 377: 355–358.
37. Jensen J, Pedersen EE, Galante P et al. Control of endodermal endocrine development by Hes-1. Nat. Genet. 2000; 24: 36–44.
38. Kageyama R, Ohtsuka T, Tomita K. The bHLH gene Hes1 regulates differentiation of multiple cell types. Mol. Cells 2000; 10: 1–7.
39. van Den Brink GR, de Santa Barbara P, Roberts DJ. Development. Epithelial cell differentiation—a Mather of choice. Science 2001; 294: 2115–2116.
40. Shroyer NF, Helmrath MA, Wang VY, Antalffy B, Henning SJ, Zoghbi HY. Intestine-specific ablation of mouse atonal homolog 1 (Math1) reveals a role in cellular homeostasis. Gastroenterology 2007; 132: 2478–2488.
41. Shinoda M, Shin-Ya M, Naito Y et al. Early-stage blocking of Notch signaling inhibits the depletion of goblet cells in dextran sodium sulfate-induced colitis in mice. J. Gastroenterol. 2010; 45: 608–617.